Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Recruiting

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

NCT05974150

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Blood Protein Disorders, +42 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Northshore University Health System Evanston, Illinois, United States
  • Univeristy of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Duke Durham, North Carolina, United States
View Trial Details
Recruiting

Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma

NCT05530421

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • University of Miami, Lennar Foundation Medical Center Coral Gables, Florida, United States
  • University of Miami, Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
View Trial Details
Recruiting

Spanish Registry of Patients With IgM Monoclonal Gammopathies

NCT05093153

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Hospital de Mérida Mérida, Badajoz, Spain
  • Hospital Son Llatzer Palma, Balearic Islands, Spain
  • Hospital Universitario Son Espases Palma de Mallorca, Balearic Islands, Spain
  • ICO Badalona - Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
View all 51 locations
View Trial Details
Recruiting

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

NCT07225738

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Seacliff Huntington Beach, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
View Trial Details
Recruiting

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

NCT06008938

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • American Thrombosis and Hemostasis Network Rochester, New York, United States
  • Medical University Vienna Vienna, Austria
  • Aarhus Universitetshospital Århus N, Denmark
  • Centre Hospitalier Universitaire de Brest / CHU Morvan Brest, France
View Trial Details
Recruiting

Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

NCT05879757

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Instituto Privado de Investigaciones Clinicas de Cordoba Córdoba, Argentina
  • Fakultni nemocnice Plzen Pilsen, Czechia
  • Vseobecna fakultni Nemocnice Prague, Czechia
  • CHU Amiens - Hopital Sud Salouël, Somme, France
View all 27 locations
View Trial Details

Related conditions